Price to Sales ratio Analysis of Addex Therapeutics Ltd - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY PS
Period Ending - Dec-23

524.72


Very Poor PS
Period Ending - Dec-22
23.32

Very Poor PS
Growth
2150.31 %
Trailing Twelve Months PS
Period Ending - Dec-23

383.21


Very Poor PS
PS Analysis of Addex Therapeutics Ltd
P/S Ratio of Addex Therapeutics Ltd with value of 383.21 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of ADXN rose handsomely by 2150.31 % this year.
PS Ratio of ADXN trending up for at least three Years.
PS Ratio with value of 0.529 was lowest in Year Dec-20 in last Five Years.
Latest PS Ratio with value of 524.72 is Greater than Average PS of 110.02 in last five years.
Other PS Related Info of ADXN that may interest you.
Addex Therapeutics Ltd Overview
CodePricePrevious PricePrice ChangeSector
ADXN8.68.64 0.463 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Very Low Value Stock
FY - Historical Price to Sales of Addex Therapeutics Ltd
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
PS524.7223.320.8380.5290.6860.2761.86
Change2150.31 %2680.95 %58.42 %-22.79 %148.20 %-85.11 %-9.27 %
You are view first 7 Records. Log in to view all 18 in Premium view
FY Chart of Price to Sales of Addex Therapeutics Ltd


Note : All Data Generated at the End of Trading Hours (EOD Data)